Role of the Alzheimer's Amyloid Precursor in Macular Degeneration
Principal Investigator
Kumar Sambamurti, PhD
Medical University of South Carolina
Charleston, SC, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2004 - March 31, 2006
Grant ID
M2004027
Summary
Recent studies have made an exciting connection between Alzheimer’s disease (AD) and age-related macular degeneration (AMD) by identifying amyloid beta protein (Aß) deposits in drusen and showing that retinal cells are very sensitive to Aß toxicity. These studies suggest that Aß could play an important role in the pathogenesis of age-related macular degeneration. Dr. Sambamurti is working to create a mouse model that overproduces Aß in the brain as well as in the retina in order to shed light on some of the pathology associated with age-related macular degeneration. His goal is to use this model to understand the effects of Aß on retinal function in general and on drusen formation in particular. He also hopes to identify risk factors for retinal degeneration and to evaluate the effects of known drug agents that might inhibit the biogenesis of Aß in the retina.
Grants
Related Grants
Macular Degeneration Research
Investigating AMD-Like Disease in Animal Models
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Brittany Carr, PhD
Investigating AMD-Like Disease in Animal Models
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Brittany Carr, PhD
Macular Degeneration Research
The Generation of Cone Photoreceptor Outer Segments
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Heike Kroeger, PhD
The Generation of Cone Photoreceptor Outer Segments
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Heike Kroeger, PhD
Macular Degeneration Research
Innovative Night Vision Tests for Age-Related Macular Degeneration
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Maximilian Pfau, MD
Innovative Night Vision Tests for Age-Related Macular Degeneration
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Maximilian Pfau, MD